ScholarX

Browsing by Abou-Alfa, GK[Abou-Alfa, Ghassan K.]Author

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 11 of 11

SCIESCOPUS
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma

El Dika, I[El Dika, Imane]; Lim, HY[Lim, Ho Yeong]; Yong, WP[Yong, Wei Peng]; Lin, CC[Lin, Chia-Chi]; Yoon, JH[Yoon, Jung-Hwan]; Modiano, M[Modiano, Manuel]; Freilich, B[Freilich, Bradley]; Choi, HJ[Choi, Hye Jin]; Chao, TY[Chao, Tsu-Yi]; Kelley, RK[Kelley, Robin K.], et al.

ArticleIssue Date2019CitationONCOLOGIST, v.24, no.6, pp.747 - E218PublisherWILEY
SCIESCOPUS
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 study

Harding, JJ[Harding, James J.]; Yang, TS[Yang, Tsai-Sheng]; Chen, YY[Chen, Yen-Yang]; Feng, YH[Feng, Yin-Hsun]; Yen, CJ[Yen, Chia-Jui]; Ho, CL[Ho, Ching-Liang]; Huang, WT[Huang, Wen-Tsung]; El Dika, I[El Dika, Imane]; Akce, M[Akce, Mehmet]; Tan, B[Tan, Benjamin], et al.

ArticleIssue Date2021CitationCANCER, v.127, no.24, pp.4585 - 4593PublisherWILEY
SCIESCOPUS
Efficacy, tolerability, and biologic activity of a novel regimen of tremelimumab (T) in combination with durvalumab (D) for patients (pts) with advanced hepatocellular carcinoma (aHCC).

Kelley, RK[Kelley, Robin Kate]; Sangro, B[Sangro, Bruno]; Harris, WP[Harris, William Proctor]; Ikeda, M[Ikeda, Masafumi]; Okusaka, T[Okusaka, Takuji]; Kang, YK[Kang, Yoon-Koo]; Qin, S[Qin, Shukui]; Tai, WMD[Tai, Wai Meng David]; Lim, HY[Lim, Ho Yeong]; Yau, T[Yau, Thomas], et al.

ArticleIssue Date2020CitationJOURNAL OF CLINICAL ONCOLOGY, v.38, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Evaluation of microsatellite instability status, a definitive predictive biomarker for immune checkpoint inhibitors (ICI), in underrepresented minorities (URM) with gastrointestinal (GI) cancers

Balogun, F[Balogun, Fiyinfolu]; Altoe, M[Altoe, Mirella]; O'Connor, C[O'Connor, Catherine]; Chowdhury, N[Chowdhury, Nobel]; Cercek, A[Cercek, Andrea]; Lee, CK[Lee, Choong-kun]; Foote, MB[Foote, Michael Bonner]; Kim, D[Kim, Daehee]; Maron, SB[Maron, Steven Brad]; Kim, DW[Kim, Dae Won], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Outcomes by occurrence of immune-mediated adverse events (imAEs) with tremelimumab (T) plus durvalumab (D) in the phase 3 HIMALAYA study in unresectable hepatocellular carcinoma (uHCC)

Lau, G[Lau, George]; Cheng, AL[Cheng, Ann-Lii]; Sangro, B[Sangro, Bruno]; Kudo, M[Kudo, Masatoshi]; Kelley, RK[Kelley, Robin Kate]; Tak, WY[Tak, Won Young]; Gasbarrini, A[Gasbarrini, Antonio]; Reig, M[Reig, Maria]; Lim, HY[Lim, Ho Yeong]; Tougeron, D[Tougeron, David], et al.

ArticleIssue Date2023CitationJOURNAL OF CLINICAL ONCOLOGY, v.41, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Outcomes in patients (pts) who had received sorafenib (S) as the only prior systemic therapy in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC).

Kelley, RK[Kelley, Robin Kate]; Ryoo, BY[Ryoo, Baek-Yeol]; Merle, P[Merle, Philippe]; Park, JW[Park, Joong-Won]; Bolondi, L[Bolondi, Luigi]; Chan, SL[Chan, Stephen Lam]; Lim, HY[Lim, Ho Yeong]; Baron, AD[Baron, Ari David]; Parnis, F[Parnis, Francis]; Knox, J[Knox, Jennifer], et al.

ArticleIssue Date2018CitationJOURNAL OF CLINICAL ONCOLOGY, v.36, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC)

Abou-Alfa, GK[Abou-Alfa, Ghassan K.]; Qin, SK[Qin, Shukui]; Ryoo, BY[Ryoo, Baek-Yeol]; Lu, SN[Lu, Sheng-Nan]; Yen, CJ[Yen, Chia-Jui]; Feng, YH[Feng, Yin-Hsun]; Lim, HY[Lim, Ho Yeong]; Izzo, F[Izzo, Francesco]; Colombo, M[Colombo, Massimo]; Sarker, D[Sarker, Debashis], et al.

ArticleIssue Date2016CitationJOURNAL OF CLINICAL ONCOLOGY, v.34, no.15PublisherAMER SOC CLINICAL ONCOLOGY
SCIESCOPUS
Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinomaopen access

Ji, JH[Ji, Jun Ho]; Ha, SY[Ha, Sang Yun]; Lee, DB[Lee, Danbi]; Sankar, K[Sankar, Kamya]; Koltsova, EK[Koltsova, Ekaterina K.]; Abou-Alfa, GK[Abou-Alfa, Ghassan K.]; Yang, JD[Yang, Ju Dong]

ArticleIssue Date2023CitationINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.24, no.8PublisherMDPI
SCIESCOPUS
Safety and efficacy of durvalumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from the phase 2 study 22 (NCT02519348)

Lim, HY[Lim, Ho Yeong]; Heo, J[Heo, Jeong]; Kim, TY[Kim, Tae-You]; Tai, WMD[Tai, Wai Meng David]; Kang, YK[Kang, Yoon-Koo]; Lau, G[Lau, George]; Kudo, M[Kudo, Masatoshi]; Tak, WY[Tak, Won Young]; Watras, M[Watras, Magdalena]; Ali, SK[Ali, Sajid K.], et al.

ArticleIssue Date2022CitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.4PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study

Kelley, RK[Kelley, Robin Kate]; Sangro, B[Sangro, Bruno]; Harris, W[Harris, William]; Ikeda, M[Ikeda, Masafumi]; Okusaka, T[Okusaka, Takuji]; Kang, YK[Kang, Yoon-Koo]; Qin, SK[Qin, Shukui]; Tai, DWM[Tai, David W-M]; Lim, HY[Lim, Ho Yeong]; Yau, T[Yau, Thomas], et al.

ArticleIssue Date2021CitationJOURNAL OF CLINICAL ONCOLOGY, v.39, no.27, pp.2991 - +PublisherLIPPINCOTT WILLIAMS & WILKINS
SCIESCOPUS
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial

Kelley, RK[Kelley, Robin Kate]; Ryoo, BY[Ryoo, Baek-Yeol]; Merle, P[Merle, Philippe]; Park, JW[Park, Joong-Won]; Bolondi, L[Bolondi, Luigi]; Chan, SL[Chan, Stephen L.]; Lim, HY[Lim, Ho Yeong]; Baron, AD[Baron, Ari D.]; Parnis, F[Parnis, Francis]; Knox, J[Knox, Jennifer], et al.

ArticleIssue Date2020CitationESMO OPEN, v.5, no.4, pp.1 - 9PublisherBMJ PUBLISHING GROUP
1
STATISTICS
Total View:
Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어